Entecavir Tablets 1 mg (X-VIR) are antiviral medicines used in the management of chronic hepatitis B (HBV) infection. Entecavir belongs to a class of medicines called nucleoside analogues and works by reducing the ability of hepatitis B virus to multiply in the body. WHO guidance recognizes entecavir as an antiviral with a high barrier to resistance and recommends it as a preferred treatment option for people with chronic hepatitis B when antiviral therapy is indicated.
Uses of Entecavir 1 mg Tablets
Entecavir is primarily prescribed for the treatment of chronic hepatitis B infection. It may help suppress HBV replication, which can reduce viral activity and support the management of liver disease.
The 1 mg strength may be prescribed in specific clinical situations, including certain patients with advanced liver disease or previous exposure to other antiviral medicines. The appropriate strength depends on factors such as treatment history, liver condition and kidney function.
Entecavir is not a cure for hepatitis B, and treatment does not eliminate the need for regular medical monitoring.
Benefits of Entecavir Tablets
One important benefit of entecavir is its ability to effectively suppress HBV replication when used appropriately. It is also recognized for its relatively high barrier to antiviral resistance compared with some older hepatitis B treatments.
For eligible patients, long-term antiviral treatment can form an important part of hepatitis B care. Regular monitoring remains necessary to evaluate viral suppression, liver health and treatment response.
WHO's current hepatitis B guidance emphasizes simplified access to appropriate antiviral treatment together with ongoing monitoring and retention in care.
Entecavir 1 mg Dosage
The Entecavir 1 mg dosage should be taken only as prescribed by a qualified healthcare professional. Dosage is not identical for every patient.
For example, WHO technical guidance lists 0.5 mg once daily for treatment-naive adults with compensated liver disease and 1 mg once daily for adults with decompensated liver disease. Previous antiviral exposure can also affect treatment selection and dosage.
Patients should take the medicine exactly as directed and should not increase, decrease or discontinue the dose without medical advice.
Important Precautions
Before using Entecavir Tablets 1 mg, patients should inform their healthcare professional about existing liver or kidney problems, previous hepatitis B treatment and other medicines they are taking.
Treatment should not be stopped suddenly without medical supervision because hepatitis B can become active again after discontinuation. Patients receiving long-term therapy may require periodic assessment of liver function, HBV activity and other relevant laboratory parameters.
Entecavir should also be used under appropriate medical supervision during pregnancy or when pregnancy is being considered. Treatment decisions should be individualized according to current clinical guidance.
Entecavir Tablets 1 mg from India
Entecavir 1 mg tablets are an established pharmaceutical option for chronic hepatitis B management. WHO's prequalification database also lists film-coated entecavir 1 mg products, demonstrating that this strength is available within internationally assessed pharmaceutical supply programs.
For pharmaceutical distributors, healthcare organizations and eligible buyers seeking Entecavir Tablets 1 mg (X-VIR) from India, product availability, documentation, packaging and export requirements should be confirmed with the supplier before placing an order.
Medical Disclaimer: This article is for general educational purposes and does not replace advice from a qualified healthcare professional. Entecavir should be used only under appropriate medical supervision and according to the approved product information applicable in the patient's country.
